Citation Impact
4 by Nobel laureates 1 from Science/Nature 70 standout
Citing Papers
Challenges and opportunities in NASH drug development
2023 Standout
Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
2023 Standout
Works of E.J. Lawitz being referenced
A multicenter, randomized, double-blind, PLB-controlled trial of Galectin-3 inhibitor (GR-MD-02) in patients with NASH cirrhosis and portal hypertension
2018
Author Peers
| Author | Hepatology | Epidemiology | Infectious Diseases | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| E.J. Lawitz | 385 | 363 | 92 | 27 | 400 | |
| Taiho Koh | 7 | 217 | ||||
| R. Chadwick Holmes | 1 | 1 | 15 | 314 | ||
| Robert A. Stratton | 24 | 863 | ||||
| H. Ike | 3 | 33 | 11 | 6 | 703 | |
| Oybek Rustamov | 12 | 390 |
All Works
Loading papers...